RT
MYOV

Robert Torray’s Myovant Sciences Ltd. MYOV Stock Holding History

Robert Torray’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79,171
Closed -$1.42M – 109
2022
Q3 		$1.42M Sell
79,171
-2,450
-3% -$39.1K 0.28% 71
2022
Q2 		$1.01M Buy
81,621
+1,753
+2% +$19.3K 0.19% 88
2022
Q1 		$1.06M Buy
79,868
+24,889
+45% +$334K 0.17% 91
2021
Q4 		$856K Sell
54,979
-19,326
-26% -$369K 0.13% 97
2021
Q3 		$1.67M Buy
74,305
+601
+0.8% +$13.2K 0.26% 83
2021
Q2 		$1.68M Buy
73,704
+10,463
+17% +$220K 0.25% 85
2021
Q1 		$1.3M Buy
63,241
+1,356
+2% +$30.9K 0.2% 90
2020
Q4 		$1.71M Buy
61,885
+623
+1% +$12.1K 0.28% 75
2020
Q3 		$861K Buy
61,262
+9,218
+18% +$171K 0.16% 94
2020
Q2 		$1.07M Buy
+52,044
New +$708K 0.2% 87

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Robert Torray's MYOV Position: Q4 2022 in Review

Robert Torray sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 79,171 shares — an estimated $1.42M sold.

Robert Torray first reported a position in MYOV in Q2 2020 and held it in 10 quarters. The position peaked at $1.71M in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Robert Torray reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Robert Torray sold 79,171 Myovant Sciences Ltd. shares in Q4 2022, an estimated $1.42M.
  • Robert Torray first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 10 quarters.
  • Robert Torray's Myovant Sciences Ltd. position peaked at $1.71M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Torray Investment Partners's 13F filing for Q4 2022, filed 8 Feb 2023.